Valganciclovir treatment in a 6-month-old infant with asymptomatic congenital cytomegalovirus infection and late hearing loss

Pediatric Infectious Disease Journal

Volumn 30, Issue 12, 2011, Pages 1124-1125

  Stronati, Mauro ^a   Garofoli, Francesca ^a   Angelini, Micol ^a   Licari, Amelia ^a   Manzoni, Paolo ^b   Lombardi, Giuseppina ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b Azienda Ospedaliera Regina Margherita   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VALGANCICLOVIR; VIRUS DNA;

ABSENCE OF SIDE EFFECTS; AUDIOMETRY; CASE REPORT; CHILD; CHILD DEVELOPMENT; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; EVOKED BRAIN STEM RESPONSE; FOLLOW UP; HEARING LOSS; HOME CARE; HUMAN; INFANT; LETTER; MAJOR CLINICAL STUDY; NEUTROPENIA; ONSET AGE; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME;

ASYMPTOMATIC INFECTIONS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HEARING LOSS, SENSORINEURAL; HUMANS; INFANT;

EID: 81855173671     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182293439     Document Type: Letter

References (12)

1. Coll O, Benoist G, Ville Y, et al. Guidelines on CMV congenital infection. J Perinat Med. 2009; 37:433-445.
2. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355-363. (Pubitemid 47425872)
3. Fowler KB, Boppana SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol. 2006;35:226-231. (Pubitemid 43053405)
4. Pass RF. Congenital cytomegalovirus infection and hearing loss. Herpes. 2005;12:50-55. (Pubitemid 41512784)
5. Kimberlin DW, Lin CY, Sanchez PJ , et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16-25. (Pubitemid 36928564)
6. Oliver SE, Cloud GA, Sánchez PJ, et al. National Institute of Allergy, Infectious Diseases Collaborative Antiviral Study Group. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46(suppl 4):S22-26.
7. Schleiss MR. Congenital cytomegalovirus infection: update on management. Curr Treat Options Neurol. 2008;10:186-192.
8. Amir J, Wolf DG, Levy I. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Eur J Pediatr. 2010;169:1061-1067.
9. Lackner A, Acham A, Alborno T, et al. Effect on hearing of ganciclovir therapy for asymptomatic congenital CMV infection: four to 10 years follow-up. J Laryngol Otol. 2009;123: 391-396.
10. Pass RF. Congenital cytomegalovirus infection: screening and treatment. J Pediatr. 2010;157:179-180.
11. Gandhi RS, Fernandez-Alvarez JR, Rabe H. Management of congenital cytomegalovirus infection: an evidence-based approach. Acta Paediatr. 2010;99:509-518.
12. Lombardi G, Garofoli F, Villani P, et al. Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection. Eur J Clin Microbiol Infect Dis. 2009; 28:1465-1470.